Sun Pharma Industries receives Warning Letter for Halol facility

Last Updated : Dec 21 2015 | 12:01 AM IST

From USFDA

Sun Pharma Industries announced that it has received a Warning Letter from the US FDA as a result of the September 2014 inspection, for its facility located at Halol, Gujarat in India.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Outcome of board meeting of Goldcoin Health Foods

Zee Learn allots equity shares

Gujarat State Petronet to acquire 13.71% stake in Sabarmati Gas

Board of UltraTech Cement approves change in directorate

First Published: Dec 19 2015 | 2:48 PM IST

Explore News

Stock Market LIVE
Stocks to Watch Today
Nifty Outlook
Stocks to buy today
Venezuela's Stock Market
Gold and Silver Rate Today
Stray Dogs Case
ICC Rejects Bangladesh Request
US Move on Venezuela Oil
Personal Finance